The 132-year-old group had been counting on a shift from electronics towards health technology to boost business and win over shareholders. But its stock has lost almost two-thirds of its value since 2021.
Adjusted earnings before interest, tax and amortisation, which exclude litigation costs, rose almost 50 per cent year on year to €359 million during the first quarter, driven by an easing of supply chain problems that have hit sales at many manufacturers.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: